🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Stage III Breast Cancer

Breast Cancer Survivorship Biorepository NCT05786664n/a1 site📍 Los Angeles University of Southern California · Tests: Biospecimen Collection, Electronic Health Record Review, Quality-of-Life Assessment, Survey Administration MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles NCT03053193n/a134 sites📍 Birmingham📍 Anchorage📍 Phoenix Agendia · Tests: MammaPrint, BluePrint, and Full-Genome Testing The DBCG Proton Trial: Photon Versus Proton Radiation Therapy for Early Breast Cancer NCT04291378NA8 sites📍 Aalborg📍 Aarhus📍 Copenhagen Danish Breast Cancer Cooperative Group · Tests: Proton versus photon radiation therapy Utidelone Versus Docetaxel in HER2-negative Locally Advanced or Metastatic Breast Cancer NCT05430399Phase 32 sites📍 Guangzhou📍 Hunan Sun Yat-sen University · Tests: utidelone, docetaxel Olaparib With Cediranib or AZD6738 for the Treatment of Advanced or Metastatic Germline BRCA Mutated Breast Cancer NCT04090567Phase 21 site📍 Houston M.D. Anderson Cancer Center · Tests: Cediranib, Ceralasertib, Olaparib Functional Imaging in Prediction of Response to Abemaciclib for Advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer NCT06179303Phase 23 sites📍 St Louis📍 Chapel Hill📍 Seattle University of Washington · Tests: Abemaciclib, Anastrozole, Biospecimen Collection, Computed Tomography, Diagnostic Imaging Testing Online Nutrition Education to Decrease the Side Effects of Chemotherapy in Patients With Breast Cancer NCT05874297NA1 site📍 Seattle Fred Hutchinson Cancer Center · Tests: Best Practice, Internet-Based Intervention, Questionnaire Administration A Study of SKB264 Versus Investigator's Choice of Chemotherapy in Subjects With Unresectable Locally Advanced, Relapsed, or Metastatic HR+/HER2- Breast Cancer Who Have Previously Failed Endocrine Therapy NCT07071337Phase 32 sites📍 Beijing📍 Guangzhou Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. · Tests: SKB264, Nab-paclitaxel, Paclitaxel, Capecitabine Personalized Exercise Program for Survivors of Breast Cancer, STEPS-BC Trial NCT07474090NA4 sites📍 Winston-Salem📍 Winston-Salem📍 Richmond Wake Forest University Health Sciences · Tests: Exercise Intervention, Educational Intervention, Supportive Care, Biospecimen Collection, Magnetic Resonance Imaging Intensity Modulated Radiotherapy (IMRT) vs. 3D-conformal Accelerated Partial Breast Irradiation (APBI) for Early Stage Breast Cancer After Lumpectomy NCT01185132Phase 35 sites📍 Aurora📍 Boulder📍 Lakewood Rocky Mountain Cancer Centers · Tests: accelerated partial breast irradiation - 3D-conformal planning, accelerated partial breast irradiation - IMRT planning A Study of the TheraBionic P1 Device in Breast Cancer NCT07218432NA8 sites📍 Clarkston📍 Detroit📍 Farmington Hills Barbara Ann Karmanos Cancer Institute · Tests: TheraBionic P1 Device A Study Comparing BL-B01D1 With Chemotherapy of Physician's Choice in Patients With Unresectable Locally Advanced, Recurrent, or Metastatic HR+/HER2- Breast Cancer After Failure of Prior Endocrine Therapy(PANKU-Breast03) NCT07648914Phase 31 site📍 Beijing Sichuan Baili Pharmaceutical Co., Ltd. · Tests: BL-B01D1, Albumin-Bound Paclitaxel, Paclitaxel, Capecitabine Topical or Oral Minoxidil for the Treatment of Endocrine Therapy-Induced Alopecia in Patients With Stage I-IV Breast Cancer NCT05417308EARLY Phase 11 site📍 Columbus Ohio State University Comprehensive Cancer Center · Tests: Minoxidil, Minoxidil, Quality-of-Life Assessment, Questionnaire Administration Avapritinib for the Treatment of CKIT or PDGFRA Mutation-Positive Locally Advanced or Metastatic Malignant Solid Tumors NCT04771520Phase 21 site📍 Houston M.D. Anderson Cancer Center · Tests: Avapritinib Disitamab Vedotin + Pyrotinib Versus THP in the First-line Treatment for HER2+ Advanced Breast Cancer Clinical Trial NCT06278870Phase 31 site📍 Guangzhou Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University · Tests: disitamab vedotin, Pyrotinib, trastuzumab, Pertuzumab, taxane drug Chemotherapy De-escalation in HR +, HER2-, Intermediate-risk Early Breast Cancer Treated With Adjuvant Ribociclib NCT07237256Phase 3138 sites📍 Amiens📍 Angers📍 Argenteuil UNICANCER · Tests: Chemotherapy followed by endocrine therapy and ribociclib treatment, De-escalation Conventionally Fractionated vs. Hypofractionated Comprehensive Nodal Irradiation for Breast Cancer Using Pencil Beam Scanning Proton Therapy NCT05856773Phase 39 sites📍 Scottsdale📍 San Diego📍 Jacksonville Proton Collaborative Group · Tests: Proton Therapy De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA) NCT04852887Phase 3832 sites📍 Birmingham📍 Mobile📍 Kingman NRG Oncology · Tests: Radiation and Endocrine Therapy (Tamoxifen, Anastrozol, Letrozole, Exemestane), Endocrine Therapy (Tamoxifen, Anastrozo… Optical Surface Monitoring Technology-Guided Large-Segment Radiotherapy for Breast Cancer NCT05804916Phase 2, Phase 31 site📍 Beijing Peking Union Medical College Hospital · Tests: Surface Guided Radiation Therapy (SGRT) Ultra-hypofractionated Whole Breast Irradiation With Lumpectomy Cavity Boost for the Treatment of Stage I-III Breast Cancer NCT06954831Phase 27 sites📍 Arcadia📍 Duarte📍 Irvine City of Hope Medical Center · Tests: Cone-Beam Computed Tomography, Hypofractionated External Beam Radiation Therapy, Questionnaire Administration, Radiatio… TeleHealth Resistance Exercise Intervention to Preserve Dose Intensity and Vitality in Elder Breast Cancer Patients NCT05535192NA4 sites📍 Boston📍 Cleveland📍 Pittsburgh Dana-Farber Cancer Institute · Tests: THRIVE, Health Education Support Program Testing the Safety and Efficacy of the Combination of Two Anti-cancer Drugs, ZEN003694 and Abemaciclib, for Adult and Pediatric Patients (12-17 Years) With Metastatic or Unresectable NUT Carcinoma, Breast Cancer and Other Solid Tumors NCT05372640Phase 17 sites📍 Los Angeles📍 Los Angeles📍 Los Angeles National Cancer Institute (NCI) · Tests: Abemaciclib, BET Bromodomain Inhibitor ZEN-3694, Biopsy Procedure, Biospecimen Collection, Diagnostic Imaging Testing SBRT Combined With PD-1 Inhibitor and Chemotherapy in Early-stage TNBC NCT06627712Phase 31 site📍 Sichuan West China Hospital · Tests: SBRT+PD-1 Inhibitor + Chemotherapy, PD-1 Inhibitor + Chemotherapy Study of Antivascular Therapy Combined With Chemotherapy Versus Chemotherapy in Adjuvant Therapy of TNBC-BLIS Patients (BCTOP-T-A03) NCT05909332Phase 315 sites📍 Beijing📍 Chongqing📍 Fuzhou Fudan University · Tests: Antivascular therapy, Chemotherapy An Optimized Ultrasound Twinkling Marker for the Imaging of Lymph Nodes in Patients With Clinically Node-Positive Breast Cancer, The UTMOST2 Trial NCT06999798Phase 11 site📍 Rochester Mayo Clinic · Tests: Diagnostic Mammography, Resection, Ultrasound Imaging, Twinkling Marker Placement Efficacy and Safety of Pyrotinib Maleate Combined With ARX788 Neoadjuvant Treatment in Breast Cancer Patients NCT04983121Phase 21 site📍 Shenyang Shengjing Hospital · Tests: Next-generation Site-specific human epidermal growth factor receptor 2 (HER2)-targeting Antibody-drug Conjugate (ARX788) Tamoxifen and Pegylated Liposomal Doxorubicin for the Treatment of Patients With Metastatic or Inoperable, Locally Advanced Triple Negative Breast Cancer NCT06434064Phase 21 site📍 Buffalo Roswell Park Cancer Institute · Tests: Biopsy, Biospecimen Collection, Computed Tomography, Echocardiography, Magnetic Resonance Imaging Pyrotinib and Trastuzumab Combined With Dalpiciclib Versus Combined With Docetaxel in Advanced HER2-Positive Breast Cancer NCT07615751Phase 31 site📍 Shanghai Fudan University · Tests: Pyrotinib 320mg po qd d1-d21 q3w and Trastuzumab 600mg IH d1 q3w Combined with Dalpicicli 125mg po gd d1-d21 q4w, Pyrot… Hypofractionated Radiotherapy in Breast Cancer Patients With Prosthetic Reconstruction NCT05491395NA1 site📍 Barretos Barretos Cancer Hospital · Tests: Hypofractionation Platinum and Polyadenosine 5'Diphosphoribose Polymerisation Inhibitor for Neoadjuvant Treatment of Triple Negative Breast Cancer and/or Germline BRCA Positive Breast Cancer NCT03150576Phase 2, Phase 330 sites📍 Cambridge📍 Burton-on-Trent📍 Manchester Cambridge University Hospitals NHS Foundation Trust · Tests: Olaparib, Paclitaxel and Carboplatin
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy